These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38542421)

  • 1. Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer.
    Clares-Pedrero I; Rocha-Mulero A; Palma-Cobo M; Cardeñes B; Yáñez-Mó M; Cabañas C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles.
    Cardeñes B; Clares I; Bezos T; Toribio V; López-Martín S; Rocha A; Peinado H; Yáñez-Mó M; Cabañas C
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche.
    Blavier L; Nakata R; Neviani P; Sharma K; Shimada H; Benedicto A; Matei I; Lyden D; DeClerck YA
    J Extracell Vesicles; 2023 May; 12(5):e12326. PubMed ID: 37194998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis.
    Szatanek R; Baj-Krzyworzeka M
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the presence of tear extracellular vesicles in Keratoconus.
    Hefley BS; Deighan C; Vasini B; Khan A; Hjortdal J; Riaz KM; Liu Y; Karamichos D
    Exp Eye Res; 2022 Nov; 224():109242. PubMed ID: 36084727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44‑hyaluronan axis plays a role in the interactions between colon cancer‑derived extracellular vesicles and human monocytes.
    Babula A; Gałuszka-Bulaga A; Węglarczyk K; Siedlar M; Baj-Krzyworzeka M
    Oncol Lett; 2023 Sep; 26(3):413. PubMed ID: 37600336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Listeria monocytogenes Infection Alters the Content and Function of Extracellular Vesicles Produced by Trophoblast Stem Cells.
    Kaletka J; Lee KH; Altman J; Kanada M; Hardy JW
    Infect Immun; 2022 Oct; 90(10):e0034722. PubMed ID: 36154271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High TSPAN8 expression in epithelial cancer cell-derived small extracellular vesicles promote confined diffusion and pronounced uptake.
    Wang T; Wang X; Wang H; Li L; Zhang C; Xiang R; Tan X; Li Z; Jiang C; Zheng L; Xiao L; Yue S
    J Extracell Vesicles; 2021 Nov; 10(13):e12167. PubMed ID: 34796683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pushing Forward the DNA Walkers in Connection with Tumor-Derived Extracellular Vesicles.
    Liu Q; Zhang Q; Yao Z; Yi G; Kang Y; Qiu Y; Yang Y; Yuan H; Fu R; Sheng W; Cheng L; Wang W; Wang H; Peng C
    Int J Nanomedicine; 2024; 19():6231-6252. PubMed ID: 38915916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside.
    Wang HX; Gires O
    Cancer Lett; 2019 Sep; 460():54-64. PubMed ID: 31233837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process.
    Tognoli ML; Dancourt J; Bonsergent E; Palmulli R; de Jong OG; Van Niel G; Rubinstein E; Vader P; Lavieu G
    Commun Biol; 2023 May; 6(1):532. PubMed ID: 37198427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.
    French KC; Antonyak MA; Cerione RA
    Semin Cell Dev Biol; 2017 Jul; 67():48-55. PubMed ID: 28104520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
    Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
    Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment.
    Umakoshi M; Takahashi S; Itoh G; Kuriyama S; Sasaki Y; Yanagihara K; Yashiro M; Maeda D; Goto A; Tanaka M
    Oncogene; 2019 Mar; 38(12):2162-2176. PubMed ID: 30459356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.
    Bose RJC; Uday Kumar S; Zeng Y; Afjei R; Robinson E; Lau K; Bermudez A; Habte F; Pitteri SJ; Sinclair R; Willmann JK; Massoud TF; Gambhir SS; Paulmurugan R
    ACS Nano; 2018 Nov; 12(11):10817-10832. PubMed ID: 30346694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles.
    Yu L; Zeng X; Hu X; Wen Q; Chen P
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113704. PubMed ID: 38113751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
    Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
    Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles originating from melanoma cells promote dysregulation in haematopoiesis as a component of cancer immunoediting.
    Mamand DR; Bazaz S; Mohammad DK; Liang X; Pavlova S; Mim C; Gabrielsson S; Nordin JZ; Wiklander OPB; Abedi-Valugerdi M; El-Andaloussi S
    J Extracell Vesicles; 2024 Jul; 13(7):e12471. PubMed ID: 38944672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of CD40L-modified tumor small extracellular vesicles for effective induction of antitumor immune response.
    Liu W; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
    Nanomedicine (Lond); 2020 Jul; 15(17):1641-1652. PubMed ID: 32664826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.